Diligence memo · auto-generated · as of July 2, 2026

Medmo, Inc.

Medmo, Inc. looks over-valued against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 3.2× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Medmo, Inc. operates in Other Health Care, based in NEW YORK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Medmo, Inc. has raised $32M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $15M on 2025-10-06.

Most recent recorded round closed around 2025-10-06.

Valuation (modeled)modeled

Provath models Medmo, Inc. at approximately $45M (range $19M–$72M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.74× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 9 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 3.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 89% of Other Health Care peers (5377 compared).

Modeled value ranks above 65% of those peers.

Closest niche peers: HelloJoy, Inc., Maui Imaging, Inc., Celltrio, Inc., Vertical Orthopaedics, Inc., AbriCare, Inc..

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.